| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Email Etiquette in the Workplace: The Email Creed |
|
Digg It - Email Etiquette in the Workplace: The Email Creed
I will give email communication the respect and value it deserves as a quick, a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product cceptable and reliable form of internet communication. I will reply to an emai ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in within 24 hours or sooner, even if the reply consists of a few words (i.e. Gre lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t, Thanks, Sorry, Yes, No, Call me, etc.). I will use spell check and I will r here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe read my emails prior to hitting the send button; because I understand that my e d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ail communications are a reflection on me. I will refrain from using abbreviat ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ions and email slang in my work related emails. I will address the person by n easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi me whenever possible and when appropriate in my email communications. I will w nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rk on developing an email voice that is even tone, respectable, positive and pe and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ sonable. I will use the blind copy email feature when sending out mass emails ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi o not to disclose the email addresses of others without their consent. I will ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a not forward emails containing the email addresses of others, unless the address dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s belong to other members of the restricted email account. I will use the atta cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin hment feature when including communication of a more private nature (i.e. Lette tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s, evaluations, information containing personal information, etc.). I will att t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel mpt to state the purpose or topic content of the email in the subject box. I w ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ill not use my business email address, provided by my employer, for personal an y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products /or inappropriate use. I will at all times use good judgment in what I communi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ate via email, understanding that such communication could be accessed by other elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip . I will refrain from using email as a substitute for person-to-person contact tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:A Key Step For New Business Owners Serviced Offices-Easing The Business Move
|